Filter Results:
(112)
Show Results For
- All HBS Web
(112)
- News (42)
- Research (59)
- Multimedia (1)
- Faculty Publications (35)
Show Results For
- All HBS Web
(112)
- News (42)
- Research (59)
- Multimedia (1)
- Faculty Publications (35)
←
Page 6 of 112
Results
- 13 Dec 2022
- News
The First Five Years: Christine Keung and Reggie Smith
operations at a venture-backed telemedicine startup that treats chronic conditions like diabetes and obesity and makes care accessible to patients in all 50 states, including West Virginia. What did you enjoy most about your HBS... View Details
- 03 Dec 2001
- Research & Ideas
Healthcare Conference Looks At Ailing Industry
Genomic Research. Even the impetus for common diseases such as diabetes and hypertension continues to elude scientists, he said. Eric S. Lander But that will change. The major achievement that underlies biology and medicine today is that... View Details
- 24 Jan 2005
- Research & Ideas
Entrepreneurial Hospital Pioneers New Model
her own physician. Reflecting on his background, Shetty wrote on his Web site that he became a doctor because of the recurrent illnesses of his parents. As a child he lived in fear that he would lose his mother; his father, a diabetic, suffered several View Details
- 23 Dec 2014
- First Look
First Look: December 23
care costs. Physicians often failed to engage patients in preventative care, which many believed would help combat the rising costs of treating chronic conditions. Diabetes and hypertension, in particular, afflicted many developed nations... View Details
Keywords: Carmen Nobel
- 01 Mar 2009
- News
Model Patient
would provide the specialists and the full range of necessary care for patients suffering from chronic diseases or disabilities such as diabetes or bad backs. Rather than leaving it to the patient to search for a specialist in one area,... View Details
- 20 Dec 2022
- News
Singing to the Corn
Nation in health care, with a focus on preventing diabetes in indigenous populations. "I quickly realized that business alone was not enough to reverse the dysfunction of some tribal economies," says Keen. Earlier, he'd experienced the... View Details
- 15 Jan 2013
- First Look
First Look: January 15
KnoopHarvard Business School Case 813-091 Amylin Pharmaceuticals brought two first-in-class diabetes drugs to market, Byetta and Symlin, in 2005, which were sold in over 80 countries with $650.7 million in sales by 2011. However, the... View Details
Keywords: Sean Silverthorne
- 01 Sep 2008
- News
Mara Aspinall
pharmaceutical companies focused their R&D on treatments for common illnesses — such as diabetes and high cholesterol — an approach that resulted in the development of blockbuster drugs. We now recognize that diseases are far more complex... View Details
- 07 Apr 2009
- First Look
First Look: April 7, 2009
http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=109057 Amylin Pharmaceuticals: Diabetes and Beyond Harvard Business School Case 809-011 Ginger Graham, CEO of Amylin Pharmaceuticals, joined the company with the expectation... View Details
Keywords: Martha Lagace
- 01 Dec 2016
- News
Alumni Books of 2016
unprecedented rates. Diabetes rates have boomed. Online data thefts have surged. Urbanization and waste have soared. What is happening? Is it globalization? Or is something much deeper taking place, something that the world had never... View Details
- ←
- 6